×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Synaptic Loss and Dysfunction Pathway
mechanism
2,945 words
KG: synaptic_loss
2026-03-23
kind:mechanism
section:mechanisms
state:published
Contents
Synaptic Loss and Dysfunction Pathway
⚙
Mechanism Info
Name
Synaptic Loss and Dysfunction Pathway
Summary
Page for Synaptic Loss and Dysfunction Pathway
Related Diseases
Alzheimer's_disease
,
phagocytosis
Knowledge Graph
Related Hypotheses (30)
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.51
Noradrenergic-Tau Propagation Blockade
Score: 0.51
Vocal Cord Neuroplasticity Stimulation
Score: 0.50
Autophagosome Maturation Checkpoint Control
Score: 0.49
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.47
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.44
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.43
VCP-Mediated Autophagy Enhancement
Score: 0.41
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Mitochondrial Calcium Buffering Enhancement via MCU Modulati
Score: 0.38
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.34
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · completed
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Show 25 more
Related Experiments (11)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Show 6 more
See Also (15)
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
TLR4 Antagonists for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Tirzepatide and Dual GIP/GLP-1 Agonists for Neurodegene
therapeutic · Pages share 5 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 5 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 5 hypotheses
Advanced Neuroimmune Interface and Glial-Neuronal Cross
therapeutic · Pages share 5 hypotheses
Section 147 Neuroimmune Interface and Glial-Neuronal Cr
therapeutic · Pages share 5 hypotheses
RIPK1 Inhibitors for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Precision Medicine Approaches for Neurodegeneration
therapeutic · Pages share 5 hypotheses
P2X7 Receptor Antagonists for Neurodegeneration
therapeutic · Pages share 5 hypotheses
nfat-pathway-modulators-neurodegeneration
therapeutic · Pages share 5 hypotheses
Neuroprotection Strategies in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Show 10 more
Knowledge Graph (3 edges)
Alzheimer's_disease
causes
synaptic_loss
tripartite_synapse_dysfunction
causes
synaptic_loss
phagocytosis
causes
synaptic_loss